REPORT ON QUALITY ASSURANCE IN PHARMACEUTICALS BY Shikher Gupta 2009A5PS626P AT HETERO DRUGS LTD. A Practice –II station of BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE‚ PILANI A REPORT ON QUALITY ASSURANCE IN PHARMACEUTICALS BY Shikher Gupta 2009A5PS626P B.Pharmacy(Hons.) Prepared in partial fulfillment of the Practice School II Course AT HETERO DRUGS LTD. A Practice School – II station of BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE‚ PILANI SEPTEMBER‚ 2012 ACKNOWLEDGEMENT
Premium Quality assurance Quality control Management
Experiment 4 - Observations of chemical change Data Table 1: Reactions Expected | | Well #/ Question | Chemicals | Reaction | | | | A | NaHCO3 – CO2 | It creates bubbles‚ it keeps uncolored | B | HCl and BTB | It changes to a strong yellow liquid | C | NH3 and BTB | It changes to blue liquid | D | HCl and blue dye | It changes green. | E | Blue dye and NaOCI | it first is blue and after add the HCl creates several colors‚ which are yellow‚ blue and green | F | NaOCl and KI
Free Acid Chemistry Purple
Why must laboratory procedures and practices be clearly communicated? By Christina Lishman INTRODUCTION: Laboratory procedures and practices are a set of guidelines which provide a clear guide on how to plan‚ perform‚ record and report all experiments safely so that human health isn’t harmed. By clearly communicating these procedures‚ it ensures quality‚ reliability and safety of the experimental activities being carried out. Laboratory procedures and practices must be clearly communicated so that
Premium Experiment Risk Case study
Singapore Compact for CSR Case Study: Singapore The case was developed with the cooperation of Singapore Compact for CSR solely for educational purposes as a contribution to the Project entitled “New Corporate Procurement Strategy on Trade in Goods and Services in APEC Region - Supply-chain options with CSR perspective -” conducted under the auspices of the Asia Pacific Economic Cooperation (APEC). The case is neither designed nor intended to illustrate the correct or incorrect management of
Premium Agriculture Organic food Organic farming
GOOD CLINICAL PRACTICE (GCP) By Dato’ Dr Ismail Merican The Ministry of Health (MOH) together with the WHO Special Programme for Research and Training in Tropical diseases (WHO-TDR) recently organised a hands-on 7-day workshop on Good Clinical Practice (GCP). The workshop was officiated by Y. Bhg. Tan Sri Dato ’ Dr Abu Bakar Suleiman‚ the Director-General of Health. At the ceremony‚ Tan Sri Dr Abu Bakar also launched the Malaysian Guidelines for Good Clinical Practice (GCP) and Guidelines for
Premium Clinical trial Informed consent Pharmaceutical industry
Federal Agency Security Practices (FASP) - NIST.gov - Computer ... csrc.nist.gov › Groups › SMAJan 28‚ 2001 – The FASP effort was initiated as a result of the success of the Federal CIO Council ’s Federal Best Security Practices (BSP) pilot effort to identify‚ ... [DOC] Network Perimeter Security Policy - Computer Security Resource ... csrc.nist.gov/.../network_security/ipdmms-perimeter-security.d...File Format: Microsoft Word - Quick View The Department Interim Network Perimeter Security Standard
Premium Security Computer security Information security
Good Food‚ Good Life Nestle • Nestlé was founded in 1867 by Henri Nestlé in Switzerland • Merged with the Anglo-Swiss Condensed Milk Company in 1905 • Today it is the world’s largest and most diversified food Company‚ and is about twice the size of its nearest competitor in the food and beverages sector. • Nestlé employ around 250‚000 people from more than 70 countries and have factories or operations in almost every country in the world Nestlé Principle • Nestlé is based on the
Premium Marketing Maggi Milk
ADVANCED WORKSHOP : REVIEW OF DRUG DEVELOPMENT IN CLINICAL TRIALS BANGKOK‚ 2-6 FEB 2009 Opening and Welcome Speech Mrs Werawan Tangkeo The Deputy Secretary General of Thai Food and Drug Administration @ The Siam City Hotel‚ Bangkok 2-6 February 2009 Dr Viner‚ Dr Stevens‚ Dr Sato‚ and Dr Sudhichai‚ Distinguished participants‚ Ladies and Gentlemen: It gives me a great pleasure to welcome all of you and chair the Opening Ceremony this morning to the “Advanced Workshop: Review of Drug Development in
Premium Clinical trial Pharmaceutical industry Drug development
answer. To end a conflict. | The competence or skill expected of a professional. | Something that logically or naturally follows from an action or condition | | | III. Writing: During the past month we learned about the 10 Rules of Good Manufacturing Practices (GMP). Please write one to two paragraphs about the consequences of not following the 10 Rules. (20 points)
Premium Dispute resolution Learning Mediation
Project Paper Summary Nucleon Inc. was founded in 1985 by Dr. Alan Ball. From 1985 until 1988 Dr. Ball and a small group of scientists researched ways of producing CRP-1 outside the body. CRP-1 is a cell regulating protein which Nucleon Inc. believed would be effective at treating burn wounds and acute kidney failure. In the field of biotechnology there was intense competition in R&D and patent protection. Nucleon believed it had a strong patent position on the CRP-1 molecule; its rights to
Premium Fixed cost Cost Pharmaceutical industry